Renaissance Technologies LLC purchased a new position in shares of PACS Group, Inc. (NYSE:PACS – Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 40,500 shares of the company’s stock, valued at approximately $1,195,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. Caas Capital Management LP acquired a new stake in shares of PACS Group during the 2nd quarter worth about $1,386,000. Bank of New York Mellon Corp bought a new stake in shares of PACS Group in the second quarter worth $2,445,000. Allspring Global Investments Holdings LLC bought a new stake in shares of PACS Group in the second quarter worth $7,513,000. Rhumbline Advisers bought a new stake in shares of PACS Group in the second quarter worth $870,000. Finally, Oppenheimer Asset Management Inc. bought a new stake in PACS Group during the second quarter valued at $552,000.
PACS Group Price Performance
PACS opened at $38.50 on Friday. PACS Group, Inc. has a 1-year low of $22.61 and a 1-year high of $42.25. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.71 and a quick ratio of 1.71. The company has a 50 day simple moving average of $38.33.
Wall Street Analysts Forecast Growth
PACS has been the subject of several recent research reports. Oppenheimer boosted their target price on shares of PACS Group from $32.00 to $40.00 and gave the company an “outperform” rating in a research note on Tuesday, August 13th. Truist Financial upped their price objective on shares of PACS Group from $36.00 to $44.00 and gave the stock a “buy” rating in a report on Thursday, August 15th. Citigroup initiated coverage on shares of PACS Group in a report on Wednesday, September 11th. They issued a “buy” rating and a $45.00 price objective for the company. Stephens upped their price target on shares of PACS Group from $37.00 to $40.00 and gave the company an “overweight” rating in a report on Tuesday, August 13th. Finally, Macquarie assumed coverage on shares of PACS Group in a report on Friday, June 28th. They issued an “outperform” rating and a $35.00 price target for the company. Seven analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $37.57.
View Our Latest Stock Analysis on PACS
PACS Group Company Profile
PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
Recommended Stories
- Five stocks we like better than PACS Group
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
- 3 Best Fintech Stocks for a Portfolio Boost
- MarketBeat Week in Review – 9/30 – 10/4
- Trading Halts Explained
- Top Streaming Companies: Who’s Winning the Battle?
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.